Chinese english Germany Japanese Korea

[1,1'-Biphenyl]-4-carboxylic acid, 4'-(trifluoroMethyl)-, Methyl ester

[1,1'-Biphenyl]-4-carboxylic acid, 4'-(trifluoroMethyl)-, Methyl ester Struktur
127783-73-7
CAS-Nr.
127783-73-7
Englisch Name:
[1,1'-Biphenyl]-4-carboxylic acid, 4'-(trifluoroMethyl)-, Methyl ester
Synonyma:
[1,1'-Biphenyl]-4-carboxylic acid, 4'-(trifluoroMethyl)-, Methyl ester
CBNumber:
CB82624367
Summenformel:
C15H11F3O2
Molgewicht:
280.24
MOL-Datei:
127783-73-7.mol
Request For Quotation

[1,1'-Biphenyl]-4-carboxylic acid, 4'-(trifluoroMethyl)-, Methyl ester Eigenschaften

Siedepunkt:
333.9±42.0 °C(Predicted)
Dichte
1.239±0.06 g/cm3(Predicted)

Sicherheit

[1,1'-Biphenyl]-4-carboxylic acid, 4'-(trifluoroMethyl)-, Methyl ester Chemische Eigenschaften,Einsatz,Produktion Methoden

[1,1'-Biphenyl]-4-carboxylic acid, 4'-(trifluoroMethyl)-, Methyl ester Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

[1,1'-Biphenyl]-4-carboxylic acid, 4'-(trifluoroMethyl)-, Methyl ester Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 9)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Hangzhou MolCore BioPharmatech Co.,Ltd. 		+86-057181025280; +8617767106207
 sales@molcore.com China 49739 58
Amadis Chemical Company Limited 		571-89925085
sales@amadischem.com China 131981 58
Nanjing JinruiJiuAn Biotechnology Co., Ltd. 025-58196018 800028039
sales@fartop.net China 2231 55
Zhengzhou Guancheng Laboratory equipment Sales 0371-88888888 272369594
 2723695949@qq.com China 4995 50
Shanghai DongYang Biotechnology Co., Ltd. 18657622632
chemsharker@126.com China 371 55
Nanjing KaiMubo Pharmaceutical Co., Ltd. 025-66162170
China 7183 55
Shanghai Sunway Pharmaceutical Technology Co.,Ltd. 021-51816796-820 13611835272
 sales2@sunwaypharm.com China 44497 58
Nanjing Shizhou Biology Technology Co.,Ltd 17301488900
 judy.xia@synzest.com China 13698 58
  • [1,1'-Biphenyl]-4-carboxylic acid, 4'-(trifluoroMethyl)-, Methyl ester
  • 127783-73-7
Copyright 2019 © ChemicalBook. All rights reserved